Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergyDeepak Mishra, Rachid Drissi, Andrew Bondoc et al.|Neuro-Oncology Advances|2025Cited by 5
Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain TumorsRachid Drissi, Shelli M. Morris, Dean Popovski et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0